CHICAGO – Treatment with Alcon’s Systane iLux for meibomian gland dysfunction resulted in improvement in clinical findings at 2 weeks and 12 months, Shane Kannarr, OD, said at Optometry’s Meeting.
“This can greatly alter our first-line treatment for meibomian gland disease,” he said.